Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
21 - 30 out of 77Page size: 10
  1. 2023
  2. Published

    Effect of finerenone on the occurrence of vision-threatening complications in patients with non-proliferative diabetic retinopathy: Pooled analysis of two studies using routine ophthalmological examinations from clinical trial participants (ReFineDR/DeFineDR)

    Rossing, Peter, Garweg, J. G., Anker, S. D., Osonoi, T., Pitt, B., Rosas, S. E., Ruilope, L. M., Zhu, D., Brinker, M., Finis, D., Leal, S., Schmelter, T. & Bakris, G., 2023, In: Diabetes, Obesity and Metabolism. 25, 3, p. 894-898 5 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  3. Effect of semaglutide on major adverse cardiovascular events by baseline kidney parameters in participants with type 2 diabetes and at high risk of cardiovascular disease: SUSTAIN 6 and PIONEER 6 post hoc pooled analysis

    Rossing, Peter, Bain, S. C., Bosch-Traberg, H., Sokareva, E., Heerspink, H. J. L., Rasmussen, S. & Mellbin, L. G., 2023, In: Cardiovascular Diabetology. 22, 11 p., 220.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD Trial

    Chertow, G. M., Correa-Rotter, R., Vart, P., Jongs, N., McMurray, J. J. V., Rossing, Peter, Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C., Heerspink, H. J. L. & Dapa-Ckd Trial Committees Investigators, D. T. C. I., 2023, In: Journal of the American Heart Association. 12, 9, 22 p., e028739.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: The DECODE-CKD Trial

    Bartholdy, K. V., Johansen, N. D., Landler, N., Skaarup, K. G., Jensen, J., Bressendorff, I., Schou, Morten, Christensen, J., Feldt-Rasmussen, Bo, Vaduganathan, M., Solomon, S., Haynes, R., Persson, F., Rossing, Peter, Køber, Lars Valeur, Zannad, F., Hansen, Ditte & Biering-Sørensen, Tor, 2023, In: Kidney360. 4, 2, p. 143-149 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Effects of Dapagliflozin on Hospitalizations in Patients With Chronic Kidney Disease: A Post Hoc Analysis of DAPA-CKD

    Schechter, M., Jongs, N., Chertow, G. M., Mosenzon, O., McMurray, J. J. V., Correa-Rotter, R., Rossing, Peter, Langkilde, A. M., Sjöström, C. D., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Annals of Internal Medicine. 176, 1, p. 59-66 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Effects of albuminuria-lowering treatments on inflammation markers: A post hoc analysis from the ROTATE trials

    Sen, T., Curovic, V. R., Jongs, N., Laverman, G. D., Kooy, A., Persson, F., Rossing, Peter & Heerspink, H. J. L., 2023, In: Diabetes, Obesity and Metabolism. 25, 8, p. 2413-2418 6 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  8. Published

    Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial

    Laursen, J. C., Rotbain Curovic, V., Kroonen, M. Y. A. M., Jongs, N., Zobel, E. H., Hansen, T. W., Frimodt-Møller, M., Laverman, G. D., Kooy, A., Persson, F., Heerspink, H. J. L., Hansen, C. S. & Rossing, Peter, 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 3064-3067 4 p.

    Research output: Contribution to journal › Letter › Research › peer-review

  9. Published

    Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline

    the FIDELIO-DKD and FIGARO-DKD investigators, T. F. A. F. I., 2023, In: Diabetes, Obesity and Metabolism. 25, 6, p. 1512-1522 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Effects of two- and twelve-weeks sodium-glucose cotransporter 2 inhibition on DNA and RNA oxidation: two randomized, placebo-controlled trials

    Larsen, E. L., Andersen, A., Kjær, L. K., Eickhoff, M. K., Frimodt-Møller, M., Persson, F., Rossing, Peter, Lykkesfeldt, Jens, Knop, Filip Krag, Vilsbøll, Tina, Rungby, Jørgen & Poulsen, Henrik Enghusen, 2023, In: Free Radical Research. 57, 2, p. 140-151

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    Efficacy of Dapagliflozin by Baseline Diabetes Medications: A Prespecified Analysis From the DAPA-CKD Study

    Beernink, J. M., Persson, F., Jongs, N., Laverman, G. D., Chertow, G. M., McMurray, J. J. V., Langkilde, A. M., Correa-Rotter, R., Rossing, Peter, Sjöström, C. D., Toto, R. D., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Diabetes Care. 46, 3, p. 602-607 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 Next

ID: 12937790